Surgical Educator Podcast

In this episode i discussed a case of acute appendicitis- how to diagnose and treat a case. If you listen the podcast carefully you will learn everything you should know about the disease.

In this episode, I discussed a case of Gastric/Duodenal ulcer perforation- how to diagnose and treat a case. If you sincerely listen this podcast you will learn everything about the case.

In this episode, i discussed the various causes of Acute Coronary Syndrome and how to diagnose them with appropriate investigations. I also discussed the various treatments for them elaborately.

In this episode i discussed the various causes of Nipple discharge and how to diagnose each one by doing appropriate invesigaions. Also discussed the various treatments for the various causes of Nipple discharge.

General Principles and Triple AssessmentThe foundation of breast cancer diagnosis is the Triple Assessment protocol, which includes clinical examination, imaging, and pathological assessment.Diagnostic accuracy reaches 99.9% when all three modalities of the Triple Assessment align.Imaging choices are age-dependent, with ultrasound preferred for women under 35 and mammography for those over 35.Core needle biopsy is superior to fine-needle aspiration because it differentiates between in situ and invasive disease and allows for hormone receptor and HER2 status testing.The majority of breast cancers are sporadic, accounting for 65% to 75% of cases, while hereditary factors like BRCA 1 and 2 mutations contribute to 5% to 10%.Classification and Clinical PresentationBreast cancer is classified into non-invasive types, such as Ductal Carcinoma In Situ (DCIS), and invasive types, of which invasive ductal carcinoma is the most common.The most frequent clinical presentation is a hard, irregular, non-tender, and poorly mobile palpable mass.Approximately 60% of breast tumors are located in the upper outer quadrant.Advanced clinical features include skin dimpling from Cooper's ligament involvement, nipple retraction, and peau d'orange due to lymphatic obstruction.Paget’s disease of the nipple presents as a unilateral, eczema-like ulceration and is often associated with an underlying malignancy.Staging and PrognosisClinical staging follows the TNM system, assessing the primary tumor size (T), regional lymph node involvement (N), and distant metastasis (M).Stage I and II are classified as early breast cancer, Stage III as locally advanced, and Stage IV as metastatic disease.The Nottingham Prognostic Index (NPI) calculates prognosis based on tumor size, nodal status, and histological grade.Five-year survival rates decrease significantly with advancing stage, from 90% in Stage I to 20% in Stage IV.Management of DCIS and Early Breast Cancer (Stages I & II)DCIS is a non-invasive cancer confined by an intact basement membrane that requires treatment to prevent progression to invasive disease.Standard treatment for DCIS is breast-conserving surgery (BCS) followed by radiation, or a mastectomy if the disease is widespread.For early invasive cancer, BCS followed by radiation is oncologically equivalent to a total mastectomy.Sentinel lymph node biopsy (SLNB) is the standard for staging the axilla in clinically node-negative patients to avoid the morbidity of full axillary dissection.Adjuvant systemic therapy, including endocrine therapy for ER-positive tumors and anti-HER2 therapy for HER2-positive tumors, is dictated by the tumor's biological profile.Management of Locally Advanced (Stage III) and Metastatic Cancer (Stage IV)Locally advanced breast cancer is treated with neoadjuvant systemic therapy as the first step to shrink the tumor and treat micrometastatic disease before surgery.Following neoadjuvant therapy, axillary lymph node dissection is mandatory if nodes were positive at presentation, regardless of the clinical response.Post-mastectomy radiation is indicated for tumors larger than 5 cm or when four or more axillary nodes are positive.Metastatic (Stage IV) disease is treatable but generally incurable, focusing on palliation and maintaining quality of life.Systemic therapy is the mainstay for Stage IV, and routine surgery on the primary tumor is avoided unless needed for local symptom control.Bone is the most common site of metastasis, requiring management with bone-modifying agents like bisphosphonates to prevent skeletal complicatio